Cargando…
Metadherin is an apoptotic modulator in prostate cancer through miR-342-3p regulation
Prostate cancer is the second most common cancer in men worldwide. This study focused to clarify the roles of Metadherin (MTDH) and miR-342-3p in prostate cancer. We identified that MTDH was up-regulated and miR-342-3p was down-regulated in the prostate tissues, and there is an inverse correlation b...
Autores principales: | Hu, Kebang, Mu, Xupeng, Kolibaba, Helena, Yin, Qinan, Liu, Chune, Liang, Xueqing, Lu, Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088108/ https://www.ncbi.nlm.nih.gov/pubmed/30108450 http://dx.doi.org/10.1016/j.sjbs.2018.04.015 |
Ejemplares similares
-
MiR-630 suppresses breast cancer progression by targeting metadherin
por: Zhou, Ci-Xiang, et al.
Publicado: (2015) -
MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells
por: Cao, Danxia, et al.
Publicado: (2020) -
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
por: Cittelly, Diana M, et al.
Publicado: (2010) -
Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
por: Fayyad-Kazan, Hussein, et al.
Publicado: (2013) -
Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia
por: Elhamamsy, Amr Rafat, et al.
Publicado: (2017)